Market Cap: $418.67M
Arcturus Therapeutics Holdings (NASDAQ: ARCT) is a San Diego-based clinical-stage mRNA company built around two proprietary technologies: the LUNAR lipid-mediated delivery platform and STARR self-ampl…
